Amylin Family Peptides and Methods for Making and Using Them
    3.
    发明申请
    Amylin Family Peptides and Methods for Making and Using Them 审中-公开
    Amylin家族肽及其制备和使用方法

    公开(公告)号:US20120196799A1

    公开(公告)日:2012-08-02

    申请号:US13445803

    申请日:2012-04-12

    IPC分类号: A61K38/22 A61P3/04

    CPC分类号: A61K38/22

    摘要: Methods for treating obesity are disclosed which comprise administration of a therapeutically effective amount of an amylin or an amylin agonist alone or in conjunction with another obesity relief agent. Additionally, methods for reducing insulin-induced weight gain are disclosed which comprise administration of a therapeutically effective amount of an amylin or an amylin agonist.

    摘要翻译: 公开了治疗肥胖症的方法,其包括单独施用治疗有效量的胰岛淀粉样多肽或胰岛淀粉样多肽激动剂或与另一种肥胖症缓解剂联合施用。 此外,公开了减少胰岛素诱导的体重增加的方法,其包括施用治疗有效量的胰岛淀粉样多肽或胰岛淀粉样多肽激动剂。

    TREATMENT OF PAIN WITH GAP JUNCTION MODULATION COMPOUNDS
    6.
    发明申请
    TREATMENT OF PAIN WITH GAP JUNCTION MODULATION COMPOUNDS 审中-公开
    用缝隙调节化合物治疗疼痛

    公开(公告)号:US20110223204A1

    公开(公告)日:2011-09-15

    申请号:US12996359

    申请日:2009-06-04

    摘要: The present invention relates to delivery, including transdermal delivery, of a therapeutically effective amount of a compound useful for modulating gap junction formation and function, including an oligonucleotide for reducing gap junction formation and function, and methods and compositions for treating a subject suffering from pain associated with a disease, disorder or condition and associated with pain, including but not limited to muscle pain, ligament pain, tendon pain, joint pain and post-operative pain.

    摘要翻译: 本发明涉及治疗有效量的用于调节间隙连接形成和功能的化合物的递送(包括透皮递送),包括用于减少间隙连接形成和功能的寡核苷酸,以及用于治疗患有疼痛的受试者的方法和组合物 与疾病,病症或病症相关并且与疼痛相关,包括但不限于肌肉疼痛,韧带疼痛,肌腱疼痛,关节疼痛和手术后疼痛。

    Methods for treating obesity
    7.
    发明授权
    Methods for treating obesity 失效
    治疗肥胖的方法

    公开(公告)号:US07910548B2

    公开(公告)日:2011-03-22

    申请号:US08870762

    申请日:1997-06-06

    IPC分类号: A61K38/00 A61K39/00

    CPC分类号: A61K38/22 Y10S514/909

    摘要: Methods for treating obesity are disclosed which comprise administration of a therapeutically effective amount of an amylin or an amylin agonist alone or in conjunction with another obesity relief agent.

    摘要翻译: 公开了治疗肥胖症的方法,其包括单独施用治疗有效量的胰岛淀粉样多肽或胰岛淀粉样多肽激动剂或与另一种肥胖症缓解剂联合施用。